Alexander Mark Schobel - 08 Jun 2022 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role: Chief Innovation/Tech Officer
Signature: /s/ Lori J. Braender, as Attorney-in-Fact
Issuer symbol: AQST
Transactions as of: 08 Jun 2022
Net transactions value: +$49,999
Form type: 4
Filing time: 10 Jun 2022, 17:26:41 UTC
Previous filing: 14 Mar 2022
Next filing: 08 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AQST	Common Stock	Purchase	$44,036	+45,871	+5.5%	$0.9600	882,871	08 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AQST	Warrant (Right to Buy)	Purchase	$5,963	+45,871		$0.1300^*	45,871	08 Jun 2022	Common Stock	45,871	$0.9600	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13.